stocks today

GOP Proposes Radical Change to 401(k) System

5 Uses for Life Insurance That Most People Haven’t Thought Of

What to Make of Merrill’s Reorg, New Ads

Bank of America’s first-quarter profits jumped 40% to $4.86 billion, up from $3.47 billion a year ago. Per-share earnings were $0.41, beating estimates and last year’s $0.38 EPS.

Revenue rose 7% to $22.25 billion from last year; on an adjusted basis, sales were $22.45 billion, which also surpassed analysts’ estimates.

Is Merrill Lynch now led by Andy Sieg wrestling with issues tied to the DOL’s new fiduciary rule?…

You are signed up!

ThinkAdvisor and the College for Financial Planning have partnered to bring you a series of helpful educational tools that you can use to take your career to the next level. ThinkAdvisor TechCenter

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources 5 Steps to Eradicate Text Messaging Risk

In this White Paper, we share five steps to help you build a risk management program that enables the benefits of text messaging while protecting…

stocks today: Vical Incorporated(VICL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Vical Incorporated (NASDAQ: VICL) shares dropped 22 percent to $3.01 after the company disclosed that its Phase 2 trial did not meet primary endpoint.

stocks today: Microbot Medical Inc. (MBOT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Microbot Medical Inc (NASDAQ: MBOT) shares shot up 51 percent to $7.76 after reporting a significant technology patent allowance in the U.S. The patent allowance covers a device for the prevention of shunt stenosis.

  • [By Lisa Levin]

    Microbot Medical Inc (NASDAQ: MBOT) shares dropped 34 percent to $2.50. Microbot Medical reported a $10 million registered direct offering

    Shares of NewLink Genetics Corp (NASDAQ: NLNK) were down 12 percent to $11.13 after the company reported that indoximod + PROVENGE resulted in statistically significant improvement in rPFS for patients with mCRPC in Phase 2 trial.

  • [By Lisa Levin]

    Shares of Microbot Medical Inc (NASDAQ: MBOT) got a boost, shooting up 15 percent to $8.77 after the company reported a 700,000 share direct offering for $3.5 million.

stocks today: Roche Holding AG (RHHBY)

Advisors’ Opinion:


    As the graphic below shows, ImmunoGen’s product pipeline is potentially significant. Furthermore, it is impressive to see the involvement and partnerships in these early stage compounds by some of the world’s leading pharmaceutical and biotech companies. This includes firms like Amgen (NASDAQ:AMGN), Roche (OTCQX:RHHBY), Bayer (OTCPK:BAYRY), Sanofi (NYSE:SNY), Eli Lilly (NYSE:LLY), and Novartis (NYSE:NVS).


    There’s still a lot to love about BMY and Opdivo, as they have the potential to be much larger. Now, notable BMY buyers could be the likes of Novartis (NYSE:NVS), Roche (OTCQX:RHHBY) or Pfizer (NYSE:PFE) – PFE has been looking to up its presence in the oncology market, and is also looking for a major purchase. BMY has a strong oncology pipeline that could work well with PFE or even Gilead (NASDAQ:GILD). GILD has an interest in oncology, and has plenty of cash for a buyout.

  • [By Keith Speights]

    Eisai (NASDAQOTH:ESALY), Novo Nordisk (NYSE:NVO), and Roche Holding Ltd. (NASDAQOTH:RHHBY) fit that description well. Each of these companies markets obesity drugs, but each also sells a broad array of other products with multiple pipeline candidates potentially on the way. Here’s why Eisai, Novo Nordisk, and Roche rank as the three best obesity-drug stocks to buy in 2017.

stocks today: Bank Of Montreal(BMO)

Advisors’ Opinion:

  • [By Mitchell Clark]

     Banks can produce solid earnings growth in the early stages of a rising interest rate environment. This Canadian bank is not expensively priced on the stock market. It currently has an over four percent dividend yield.

    The Canadian banking market is small, but it’s protected from foreign ownership and most of the names in this industry have great long-term track records on the stock market.

stocks today: The Advisory Board Company(ABCO)

Advisors’ Opinion:


    Advisory Board (ABCO) on Friday reached a settlement with activist investor Elliott Management’s Paul Singer that ends the threat of a director battlefor nowas the healthcare technology and consulting firm continues to explore strategic alternatives, such as a sale.

stocks today: Staffing 360 Solutions, Inc.(STAF)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap staffing stock Staffing 360 Solutions Inc (NASDAQ: STAF), which is in the midst of a global buy-and-build strategy through the acquisition of domestic and international staffing organizations with operations in the US and UK, hasannounced thatthe Company and its board of directors have rejected a recent buyout proposal for $1.10 per share by the Jackson Investment Group.The proposal by Jackson Investment Group was received by the Company on Thursday, March 23, 2017 and delivered to the Board on Friday, March 24, 2017.

  • [By James E. Brumley]

    The staffing industry – and the IT staffing industry in particular – is poised for tremendous growth in the foreseeable future, and that rising tide bodes very well for Staffing 360 Solutions Inc. (NASDAQ:STAF).

  • [By Bryan Murphy]

    Staffing agencies like Robert Half International Inc. (NYSE:RHI) and ManpowerGroup Inc. (NYSE:MAN) may want to look over their shoulder. Though both are bigger and more established, their size and the waning need for physical, human workers in an increasingly-digital and roboticized world ultimately works against both organizations. That paradigm shift doesn’t matter much to a young, up-coming-staffing agency called Staffing 360 Solutions Inc (NASDAQ:STAF) though. Indeed, the trend of computer-based everything leaves Staffing 360 Solutions in the proverbial cat-bird’s seat. Its fiscal Q2 numbers verify the company is in the right place at the right time.

    Those numbers? Revenue of $47.1 million was up 14%, and gross profits of $8.1 million were higher by 8.4% on a year-over-year basis. Moreover, the net loss of $1.5 million was a marked improvement on the year-ago loss of $3.5 million, and the EBITDA of $1.4 million was about the same. Operating expenses fell from 22% of revenue a year earlier to only 17% last quarter, with more such progress on the way.

    Perhaps most important, Staffing 360 Solutions saw organic growth of 7%, meaning the top line bumped up by that much not because of acquisitions, but because it’s existing divisions expanded their client base and billings by 7%.

    And last quarter’s progress has been the norm for several quarters now.

    While STAF is proving outpacing the growth from bigger names like ManpowerGroup and Robert Half International, it can’t come as a complete surprise. Staffing 360 Solutions is focused on the IT sliver of the staffing industry, connecting companies with the technology-skilled programmers, cybersecurity specialists, and computer networking personnel modern organizations increasingly need.

    There are several data nuggets that point in the same direction, but perhaps none as telling as a recent conclusion from technology research outfit IDC speaks volumes. IDC believes that by the

  • [By Matthew Briar]

    How does the old saying go? Numbers don’t lie? If that’s the case (and it IS true – numbers don’t lie), then Staffing 360 Solutions Inc (NASDAQ:STAF) remains in the right spot at the right time, and STAF shareholders have much to look forward to.

    Staffing 360 Solutions is a young and enterprising IT staffing firm that, for the record, is getting real big, real fast, by smartly and cost-effectively acquiring its way into a size and scale by converting a fragmented and less-effective (and less profitable) group of information-technology similar staffing agencies into a cohesive, more profitable singular unit.

    And a recent batch of data confirms that the company is barking up the right tree, so to speak.

    The latest round of numbers that bolster the bullish case for STAF are supplied by industry-research group Staffing Industry Analysts. Per the groups monthly Pulse Survey, in January, demand for IT staffing grew 11% on a year-over-year basis, improving on the 5% growth rate this sliver of the temporary-staffing industry saw in January of 2016. That’s the second-best growth pace among several the SIA monitors. Only demand for allied health workers was stronger.

    Of course, the news comes as no real surprise to regular followers of Staffing 360 Solutions, who have seen the company grow into a powerhouse, producing $47.1 million in revenue as of the most recent quarter. That was up 14% on a year-over-year basis, and half of that growth was organic (the other half came from smart acquisitions). Shareholders have seen the company grow from essentially nothing three years ago to what will eventually be a company driving $300 million in annual revenue.

    It’s not as if Staffing Industry Analysts are the only group out there saying the IT staffing arena is a red-hot opportunity. Technology research outfit recently opined that by the end of 2017, two-thirds of the CEOs of Global 2000 companies will have digital transformation at the ce

Leave a Reply

Your email address will not be published. Required fields are marked *